• Report Description
  • Table Of Content
  • Request Methodology

Global Uveitis Treatment market accounted for USD 629.7 million in 2017 and is estimated to reach USD 973.2 million in 2023, registering a compound annual growth rate (CAGR) of 5.8% between 2017 and 2023.

Growth Drivers & Barriers:

Rising geriatric population in various developed nations is anticipated to positively impact the growth of the market during the forecast period. Addition to that, rising prevalence of uveitis is driving the demand for advanced treatment which in turn, is expected to intensify the growth of the market. Moreover, increasing disposable income of the population coupled with rising spending on healthcare is also believed to positively impact the growth of the market.

Rising expenditure on research & development is set to spearhead the growth of the market. Manufacturers of various pharmaceuticals company are engaged in enhancing their product portfolio by adding new products. Further, increasing number of clinical trials in U.K., France and other countries also bodes well for the growth of the market.

Rapid development of healthcare infrastructure in various developing nations such as India, China and others is expected to aid the growth of global uveitis treatment market during the forecast period. Further, favorable government healthcare policies & plans are also believed to impel the growth of the market.

Regional Outlook:

In the terms of geography, the uveitis treatment market is analyzed into North America, Latin America, Asia Pacific, Europe and Middle East & Africa. Among these regions, North America is slated to account for highest percentage of market share in overall uveitis treatment market during the forecast period. Asia Pacific uveitis treatment market accounted for second position in overall uveitis treatment market in 2017.

Segmentation
The research offers a comprehensive analysis of uveitis treatment market with respect to following sub-markets:

By Type
- Anterior Uveitis
- Posterior Uveitis
- Intermediate Uveitis
- Panuveitis

By Treatment
- Anti-inflammatory Medications
- Antibiotic Medications
- Immunosuppresive Medications

By Geography
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Competitive Landscape
The report profiles various major market players such as;

- XOMA Corporation
- pSivida Corp.
- Alcon, Inc.
- AbbVie Inc.
- Allergan, Inc.
- OpthaliX Inc.
- Enzo Biochem Inc.
- Regeneron Pharmaceuticals
- Bausch & Lomb Incorporated
- Santen Pharmaceuticals Co., Ltd.
- Others Major and Niche Players

Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, risk analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development expansion and other market activities.

The study also provides company’s positioning and market share in uveitis treatment market.

Timeline Considered for Analysis:
- 2017: Base Year
- 2018: Estimated Year
- 2019 to 2023: Forecasted Year

Research Scope and Deliverables
Overview & Executive Summary
Market Drivers, Trends, Challenges and Opportunities
Market Size and Forecast Projections
Macroeconomic Indicators of Various Countries Impacting the Growth of the Market
Extensive Coverage of Industry Players including Recent Product Launches and Market Activities
Porter’s Five Force Analysis
Market Segmentation Analysis:
Industry report analyzes the global uveitis treatment market by the following segments:
- Type
- Treatment

Geographic Market Analysis:
The report offers separate analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In addition, further breakdown of market data and analysis of region into countries is covered in the report.

Key Questions Answered in the Global Uveitis Treatment Industry Report:

- What is the overall market size in 2017? What will be the market growth during the forecast period i.e. 2018-2023?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?

1. Executive Summary

2. Methodology
2.1. Research Methodology
2.2. Geographic Scope
2.3. Years Considered

3. Market Overview
3.1. Overview and Definition
3.1.1. Market Definition
3.1.2. Geographic Regions Definition
3.1.3. Uveitis Definition
3.2. Industry Development
3.3. Porter’s Five Force Analysis
3.4. Industry Value Chain Analysis
4. Growth Drivers & Barriers in Global Uveitis Market
5. Trends in Global Uveitis Market
6. Global Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

7. Global Uveitis Market Segmentation Analysis, By Type
7.1. Introduction
7.2. BPS Analysis by Type
7.3. Market Attractiveness by Type
7.4. Anterior Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
7.5. Posterior Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
7.6. Intermediate Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
7.7. Panuveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

8. Global Uveitis Market Segmentation Analysis, By Treatment
8.1. Introduction
8.2. BPS Analysis By Treatment
8.3. Market Attractiveness By Treatment
8.4. Anti-inflammatory Medications Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
8.5. Antibiotic Medications Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
8.6. Immunosuppresive Medications Single Specialty Centers Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

9. Geographical Analysis
9.1. North America Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.1. By Type
9.1.1.1. Introduction
9.1.1.2. BPS Analysis by Type
9.1.1.3. Market Attractiveness by Type
9.1.1.4. Anterior Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.1.5. Posterior Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.1.6. Intermediate Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.1.7. Panuveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.2. By Treatment
9.1.2.1. Introduction
9.1.2.2. BPS Analysis By Treatment
9.1.2.3. Market Attractiveness By Treatment
9.1.2.4. Anti-inflammatory Medications Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.2.5. Antibiotic Medications Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.2.6. Immunosuppresive Medications Single Specialty Centers Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.3. By Country
9.1.3.1. Introduction
9.1.3.2. BPS Analysis By Country
9.1.3.3. Market Attractiveness By Country
9.1.3.4. U.S. Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.3.5. Canada Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

9.2. Europe Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.1. By Type
9.2.1.1. Introduction
9.2.1.2. BPS Analysis by Type
9.2.1.3. Market Attractiveness by Type
9.2.1.4. Anterior Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.1.5. Posterior Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.1.6. Intermediate Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.1.7. Panuveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.2. By Treatment
9.2.2.1. Introduction
9.2.2.2. BPS Analysis By Treatment
9.2.2.3. Market Attractiveness By Treatment
9.2.2.4. Anti-inflammatory Medications Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.2.5. Antibiotic Medications Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.2.6. Immunosuppresive Medications Single Specialty Centers Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3. By Country
9.2.3.1. Introduction
9.2.3.2. BPS Analysis By Country
9.2.3.3. Market Attractiveness By Country
9.2.3.4. Germany Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3.5. United Kingdom Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3.6. France Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3.7. Italy Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3.8. Spain Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3.9. Russia Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3.10. Rest of Europe Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

9.3. Asia Pacific Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.1. By Type
9.3.1.1. Introduction
9.3.1.2. BPS Analysis by Type
9.3.1.3. Market Attractiveness by Type
9.3.1.4. Anterior Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.1.5. Posterior Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.1.6. Intermediate Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.1.7. Panuveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.2. By Treatment
9.3.2.1. Introduction
9.3.2.2. BPS Analysis By Treatment
9.3.2.3. Market Attractiveness By Treatment
9.3.2.4. Anti-inflammatory Medications Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.2.5. Antibiotic Medications Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.2.6. Immunosuppresive Medications Single Specialty Centers Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3. By Country
9.3.3.1. Introduction
9.3.3.2. BPS Analysis By Country
9.3.3.3. Market Attractiveness By Country
9.3.3.4. China Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.5. India Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.6. Japan Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.7. Indonesia Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.8. Taiwan Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.9. Australia Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.10. New Zealand Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.11. Rest of Asia Pacific Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

9.4. Latin America Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.1. By Type
9.4.1.1. Introduction
9.4.1.2. BPS Analysis by Type
9.4.1.3. Market Attractiveness by Type
9.4.1.4. Anterior Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.1.5. Posterior Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.1.6. Intermediate Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.1.7. Panuveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.2. By Treatment
9.4.2.1. Introduction
9.4.2.2. BPS Analysis By Treatment
9.4.2.3. Market Attractiveness By Treatment
9.4.2.4. Anti-inflammatory Medications Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.2.5. Antibiotic Medications Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.2.6. Immunosuppresive Medications Single Specialty Centers Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.3. By Country
9.4.3.1. Introduction
9.4.3.2. BPS Analysis By Country
9.4.3.3. Market Attractiveness By Country
9.4.3.4. Brazil Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.3.5. Mexico Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.3.6. Rest of Latin America Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

9.5. Middle East & Africa Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.1. By Type
9.5.1.1. Introduction
9.5.1.2. BPS Analysis by Type
9.5.1.3. Market Attractiveness by Type
9.5.1.4. Anterior Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.1.5. Posterior Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.1.6. Intermediate Uveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.1.7. Panuveitis Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.2. By Treatment
9.5.2.1. Introduction
9.5.2.2. BPS Analysis By Treatment
9.5.2.3. Market Attractiveness By Treatment
9.5.2.4. Anti-inflammatory Medications Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.2.5. Antibiotic Medications Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.2.6. Immunosuppresive Medications Single Specialty Centers Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.3. By Country
9.5.3.1. Introduction
9.5.3.2. BPS Analysis By Country
9.5.3.3. Market Attractiveness By Country
9.5.3.4. GCC Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.3.5. North Africa Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.3.6. South Africa Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.3.7. Rest of Middle East & Africa Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

10. Company Profile
10.1. Company Analysis
10.1.1. XOMA Corporation
10.1.1.1. Company Overview
10.1.1.2. Product Offered
10.1.1.3. Business Strategy
10.1.1.4. Financials
10.1.1.5. SWOT Analysis
10.1.1.6. Market Share Analysis
10.1.1.7. Key Achievements & Developments
10.1.2. pSivida Corp.
10.1.2.1. Company Overview
10.1.2.2. Product Offered
10.1.2.3. Business Strategy
10.1.2.4. Financials
10.1.2.5. SWOT Analysis
10.1.2.6. Market Share Analysis
10.1.2.7. Key Achievements & Developments
10.1.3. pSivida Corp.
10.1.3.1. Company Overview
10.1.3.2. Product Offered
10.1.3.3. Business Strategy
10.1.3.4. Financials
10.1.3.5. SWOT Analysis
10.1.3.6. Market Share Analysis
10.1.3.7. Key Achievements & Developments
10.1.4. AbbVie Inc.
10.1.4.1. Company Overview
10.1.4.2. Product Offered
10.1.4.3. Business Strategy
10.1.4.4. Financials
10.1.4.5. SWOT Analysis
10.1.4.6. Market Share Analysis
10.1.4.7. Key Achievements & Developments
10.1.5. Allergan, Inc.
10.1.5.1. Company Overview
10.1.5.2. Product Offered
10.1.5.3. Business Strategy
10.1.5.4. Financials
10.1.5.5. SWOT Analysis
10.1.5.6. Market Share Analysis
10.1.5.7. Key Achievements & Developments
10.1.6. Allergan, Inc.
10.1.6.1. Company Overview
10.1.6.2. Product Offered
10.1.6.3. Business Strategy
10.1.6.4. Financials
10.1.6.5. SWOT Analysis
10.1.6.6. Market Share Analysis
10.1.6.7. Key Achievements & Developments
10.1.7. Enzo Biochem Inc.
10.1.7.1. Company Overview
10.1.7.2. Product Offered
10.1.7.3. Business Strategy
10.1.7.4. Financials
10.1.7.5. SWOT Analysis
10.1.7.6. Market Share Analysis
10.1.7.7. Key Achievements & Developments
10.1.8. Regeneron Pharmaceuticals
10.1.8.1. Company Overview
10.1.8.2. Product Offered
10.1.8.3. Business Strategy
10.1.8.4. Financials
10.1.8.5. SWOT Analysis
10.1.8.6. Market Share Analysis
10.1.8.7. Key Achievements & Developments
10.1.9. Bausch & Lomb Incorporated
10.1.9.1. Company Overview
10.1.9.2. Product Offered
10.1.9.3. Business Strategy
10.1.9.4. Financials
10.1.9.5. SWOT Analysis
10.1.9.6. Market Share Analysis
10.1.9.7. Key Achievements & Developments
10.1.10. Santen Pharmaceuticals Co., Ltd.
10.1.10.1. Company Overview
10.1.10.2. Product Offered
10.1.10.3. Business Strategy
10.1.10.4. Financials
10.1.10.5. SWOT Analysis
10.1.10.6. Market Share Analysis
10.1.10.7. Key Achievements & Developments
10.1.11. Other Major & Niche Players

Select License Type
  • Single User License $4185 USD
  • Multi-User License $5175 USD
  • Corporate User License $5895 USD

Request For Customization



Request Customization

Check Discount



Request Discount

Corporate Clients

More than 200 Clients